BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 28578922)

  • 1. Depression and clinical high-risk states: Baseline presentation of depressed vs. non-depressed participants in the NAPLS-2 cohort.
    Kline ER; Seidman LJ; Cornblatt BA; Woodberry KA; Bryant C; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Addington J
    Schizophr Res; 2018 Feb; 192():357-363. PubMed ID: 28578922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. North American Prodrome Longitudinal Study (NAPLS 2): The Prodromal Symptoms.
    Addington J; Liu L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; McGlashan TH
    J Nerv Ment Dis; 2015 May; 203(5):328-35. PubMed ID: 25919383
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome.
    Walder DJ; Holtzman CW; Addington J; Cadenhead K; Tsuang M; Cornblatt B; Cannon TD; McGlashan TH; Woods SW; Perkins DO; Seidman LJ; Heinssen R; Walker EF
    Schizophr Res; 2013 Mar; 144(1-3):43-50. PubMed ID: 23340377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Global Functioning: Social and Role Scales-Further Validation in a Large Sample of Adolescents and Young Adults at Clinical High Risk for Psychosis.
    Carrión RE; Auther AM; McLaughlin D; Olsen R; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cornblatt BA
    Schizophr Bull; 2019 Jun; 45(4):763-772. PubMed ID: 30351423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of violent behaviour in young people at clinical high risk for psychosis from the North American Prodrome Longitudinal Studies consortium.
    Tronick LN; Mirzakhanian H; Addington J; Bearden CE; Cannon TD; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Stone W; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
    Early Interv Psychiatry; 2023 Aug; 17(8):759-770. PubMed ID: 36627192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal impact of trauma in the North American Prodrome Longitudinal Study-3.
    Farris MS; Braun A; Liu L; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Stone WS; Tsuang MT; Walker EF; Woods SW; Cannon TD; Addington J
    Early Interv Psychiatry; 2022 Nov; 16(11):1211-1216. PubMed ID: 35152553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep Disturbance in Individuals at Clinical High Risk for Psychosis.
    Zaks N; Velikonja T; Parvaz MA; Zinberg J; Done M; Mathalon DH; Addington J; Cadenhead K; Cannon T; Cornblatt B; McGlashan T; Perkins D; Stone WS; Tsuang M; Walker E; Woods SW; Keshavan MS; Buysse DJ; Velthorst E; Bearden CE
    Schizophr Bull; 2022 Jan; 48(1):111-121. PubMed ID: 34536012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis.
    Goldsmith DR; Haroon E; Miller AH; Addington J; Bearden C; Cadenhead K; Cannon T; Cornblatt B; Mathalon D; McGlashan T; Seidman L; Tsuang M; Woods SW; Walker EF; Perkins DO
    Brain Behav Immun; 2019 Feb; 76():268-274. PubMed ID: 30496778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reliability and validity of the Calgary Depression Scale for Schizophrenia (CDSS) in youth at clinical high risk for psychosis.
    Addington J; Shah H; Liu L; Addington D
    Schizophr Res; 2014 Mar; 153(1-3):64-7. PubMed ID: 24439270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.
    Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS
    Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Symptom dimensions and functional impairment in early psychosis: more to the story than just negative symptoms.
    Fulford D; Niendam TA; Floyd EG; Carter CS; Mathalon DH; Vinogradov S; Stuart BK; Loewy RL
    Schizophr Res; 2013 Jun; 147(1):125-131. PubMed ID: 23587696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bullying in clinical high risk for psychosis participants from the NAPLS-3 cohort.
    Braun A; Liu L; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan M; Mathalon DH; McGlashan TH; Perkins DO; Seidman LJ; Stone W; Tsuang MT; Walker EF; Woods SW; Cannon TD; Addington J
    Soc Psychiatry Psychiatr Epidemiol; 2022 Jul; 57(7):1379-1388. PubMed ID: 35113189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis.
    Addington J; Stowkowy J; Liu L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Bearden CE; Mathalon DH; Santesteban-Echarri O; Woods SW
    Psychol Med; 2019 Jul; 49(10):1670-1677. PubMed ID: 30176955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Course of psychotic symptoms, depression and global functioning in persons at clinical high risk of psychosis: Results of a longitudinal observation study over three years focusing on both converters and non-converters.
    Hengartner MP; Heekeren K; Dvorsky D; Walitza S; Rössler W; Theodoridou A
    Schizophr Res; 2017 Nov; 189():19-26. PubMed ID: 28139360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Depressive symptoms in first episode psychosis: a one-year follow-up study.
    Sönmez N; Romm KL; Andreasssen OA; Melle I; Røssberg JI
    BMC Psychiatry; 2013 Apr; 13():106. PubMed ID: 23560591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study.
    Meyer EC; Carrión RE; Cornblatt BA; Addington J; Cadenhead KS; Cannon TD; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; Heinssen R; Seidman LJ;
    Schizophr Bull; 2014 Nov; 40(6):1452-61. PubMed ID: 24550526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sex- and Age-Specific Deviations in Cerebellar Structure and Their Link With Symptom Dimensions and Clinical Outcome in Individuals at Clinical High Risk for Psychosis.
    Sefik E; Boamah M; Addington J; Bearden CE; Cadenhead KS; Cornblatt BA; Keshavan MS; Mathalon DH; Perkins DO; Stone WS; Tsuang MT; Woods SW; Cannon TD; Walker EF
    Schizophr Bull; 2023 Mar; 49(2):350-363. PubMed ID: 36394426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study.
    Devoe DJ; Lu L; Cannon TD; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Walker EF; Mathalon DH; Bearden CE; Addington J
    Schizophr Res; 2021 Jan; 227():28-37. PubMed ID: 32362460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Depressive symptoms are associated with (sub)clinical psychotic symptoms in patients with non-affective psychotic disorder, siblings and healthy controls.
    Klaassen RM; Heins M; Luteijn LB; van der Gaag M; van Beveren NJ;
    Psychol Med; 2013 Apr; 43(4):747-56. PubMed ID: 22804999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium.
    Alderman T; Addington J; Bearden C; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Cadenhead KS
    Early Interv Psychiatry; 2015 Dec; 9(6):467-75. PubMed ID: 24576057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.